Parkinson’s Disease

A common bacteria that boosts digestive health can slow, and even reverse, build-up of a protein associated with Parkinson’s, according to new research[1]. The findings could pave the way for future studies that gauge how supplements such as probiotics impact the condition. Building on previous research linking brain function to gut bacteria, this study in… Read more

A drug that brings the benefits gained from medical cannabis without the “high” or other side effects may help to unlock a new treatment for Parkinson’s disease. The drug, known as HU-308, reduces devastating involuntary movements called dyskinesias, a side effect from years of treatment for Parkinson’s disease. “Our study suggests that a derivative of… Read more

New research may clarify why the effects of deep-brain stimulation can differ so much — and indicate the way to advancing the treatment[1]. People with severe Parkinson’s disease or other neurological conditions that cause intractable symptoms such as uncontrollable shaking, muscle spasms, seizures, obsessive thoughts, and compulsive behaviors are sometimes treated with electric stimulators placed… Read more

Chaperone proteins in human cells cooperate dynamically with α-Synuclein, a protein strongly associated with Parkinson’s disease. A disrupted relationship to these “bodyguards” leads to cell damage and the formation of Lewy bodies typical for Parkinson’s, researchers from the University of Basel’s Biozentrum report. The assisting proteins, known as chaperones, are constantly protecting α-Synuclein in human… Read more